United States Radiotherapy Market

Market Overview:

United States radiotherapy market size is projected to exhibit a growth rate (CAGR) of 4.40% during 2024-2032. The growing development of more sophisticated radiotherapy machines, rising integration of artificial intelligence (AI) and machine learning (ML) for various purposes, and increasing combination with other cancer treatments, such as immunotherapy and chemotherapy, represent some of the key factors driving the market.

Radiotherapy, also known as radiation therapy, is a medical treatment used primarily for cancer, where high-energy radiation is employed to damage the deoxyribonucleic acid (DNA) of cancer cells, causing them to die or reproduce more slowly. It is manufactured through various sophisticated technologies, such as linear accelerators or radioactive sources like cobalt-60. It can be delivered externally via external beam radiation, or internally through brachytherapy, where radioactive material is placed inside or near the tumor. It is often delivered in fractions, spreading treatment over several sessions, which helps protect healthy tissue while delivering the necessary dose to the tumor. It can be used alone or in combination with other treatments like surgery or chemotherapy. It helps to cure cancer, particularly in early stages, and alleviate symptoms in more advanced cases. It offers patients a non-invasive option with relatively fewer side effects compared to other treatments. It can significantly improve quality of life by reducing pain and other symptoms caused by tumors.

United States Radiotherapy Market Trends:

At present, the rising development of more sophisticated radiotherapy machines, like advanced linear accelerators, enabling more precise targeting of tumors and minimizing damage to surrounding healthy tissue, represents one of the major factors impelling the market growth in the United States. In addition, increasing preferences for personalized medicine, which aims to adjust radiation doses and techniques as per the genetic makeup of the patient, type and stage of the cancer, and other factors is contributing to the market growth in the country. Besides this, there is a growing number of mergers and acquisitions (M&A), as companies seek to expand their portfolios and capabilities in radiotherapy. These collaborations often aim to combine clinical expertise with technological advancements, leading to innovation and improved patient care. Moreover, the rising recognition of the role of radiotherapy in palliative care to alleviate symptoms and improve quality of life is supporting the market growth. This application of radiotherapy is particularly important in an aging population with a high prevalence of chronic illnesses. Additionally, the increasing integration of artificial intelligence (AI) and machine learning (ML) in radiotherapy for various purposes, ranging from improving the precision of radiation dose delivery for optimizing treatment planning and predicting patient responses to radiotherapy is bolstering the market growth in the country. Apart from this, the rising focus on using radiotherapy in combination with other cancer treatments, such as immunotherapy and chemotherapy as they can enhance the overall effectiveness of treatment, potentially leading to better patient outcomes is offering a favorable market outlook.

United States Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type, application, and end user.

Type Insights:

• External Beam Radiation Therapy  
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Tomotherapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Proton Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
• Internal Radiation Therapy/Brachytherapy
• Systemic Radiation Therapy
   

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, Stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy, and systemic radiation therapy.

Application Insights:

• Skin and Lip Cancer
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Lung Cancer
• Others
   

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others.

End User Insights:

• Hospitals
• Cancer Research Institutes
• Ambulatory and Radiotherapy Centers
   

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.

Regional Insights:

• Northeast
• Midwest
• South
• West
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Radiotherapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the United States radiotherapy market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the United States radiotherapy market?
• What is the breakup of the United States radiotherapy market on the basis of type?
• What is the breakup of the United States radiotherapy market on the basis of application?
• What is the breakup of the United States radiotherapy market on the basis of end user?
• What are the various stages in the value chain of the United States radiotherapy market? 
• What are the key driving factors and challenges in the United States radiotherapy?
• What is the structure of the United States radiotherapy market and who are the key players?
• What is the degree of competition in the United States radiotherapy market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States radiotherapy market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States radiotherapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States radiotherapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.